Larry P. Feigen

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

Abla A. Creasey, Alvin Chang, Larry P. Feigen et al. · Journal of Clinical Investigation · 1993 · 549 citations · Full text

Immunology, Inflammation, Thrombosis +21

Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2

Philip J. Kadowitz, B. M. Chapnick, Larry P. Feigen et al. · Journal of Applied Physiology · 1978 · 150 citations

Inflammatory Lung Disease, Lung Inflammation, Pharmacotherapy +17

The Amino-terminal One-third of αIIb Defines the Ligand Recognition Specificity of Integrin αIIbβ3

Joseph C. Loftus, Carol Halloran, Mark H. Ginsberg et al. · Journal of Biological Chemistry · 1996 · 74 citations · Full text

Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.

Ethan J. Haskel, S P Adams, Larry P. Feigen et al. · Circulation · 1989 · 66 citations · Full text

Canine Femoral Arteries, Biomedical Engineering, Thrombosis +18

SC-54684A: An Orally Active Inhibitor of Platelet Aggregation

Nancy S. Nicholson, Susan G. Panzer‐Knodle, Anita K. Salyers et al. · Circulation · 1995 · 65 citations